Effect of Efflux on Telithromycin and Macrolide Susceptibility in Haemophilus influenzae
Open Access
- 1 March 2006
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 50 (3), 893-898
- https://doi.org/10.1128/aac.50.3.893-898.2006
Abstract
This study investigated the presence of telithromycin and azithromycin efflux in 58 clinical strains of Haemophilus influenzae with various susceptibilities to macrolides, azalides, and ketolides. Efflux pumps were studied by measuring accumulation of radioactive [ 3 H]telithromycin and [ N -methyl- 3 H]azithromycin in the presence and absence of carbonyl m -chlorophenylhydrazone (CCCP), a protonophore. In 17 strains for which the telithromycin MICs were 0.06 to 0.5 μg/ml (azithromycin MICs, ≤0.06 to 0.125 μg/ml; clarithromycin MICs, ≤0.06 to 2 μg/ml), telithromycin and azithromycin accumulations were high without CCCP and not affected by its addition, which indicates absence of efflux. In 22 strains for which the telithromycin MICs were 0.25 to 4 μg/ml (azithromycin MICs, 0.25 to 1 μg/ml; clarithromycin MICs, 1 to 8 μg/ml), initially low levels of telithromycin accumulation became higher after addition of CCCP, indicating a functioning efflux pump. Nineteen strains for which the telithromycin MICs were ≥2 μg/ml had efflux as well as various mutations in ribosomal proteins L4, L22, and/or 23S rRNA (domains II and V). Of these 19 strains, the telithromycin MICs (≥8 μg/ml) for 17 of them were significantly raised (azithromycin, MICs 4 to >32 μg/ml; clarithromycin MICs, 8 to >32 μg/ml). From these results we conclude that telithromycin efflux with or without additional ribosomal alterations is present in all H. influenzae strains, except for those for which the telithromycin MICs were very low.Keywords
This publication has 26 references indexed in Scilit:
- The AcrAB-TolC Pump Is Involved in Macrolide Resistance but Not in Telithromycin Efflux inEnterobacter aerogenesandEscherichia coliAntimicrobial Agents and Chemotherapy, 2004
- Inability of L22 ribosomal protein alteration to increase macrolide MICs in the absence of efflux mechanism in Haemophilus influenzae HMC-SJournal of Antimicrobial Chemotherapy, 2004
- Identification of the Haemophilus influenzae tolC Gene by Susceptibility Profiles of Insertionally Inactivated Efflux Pump MutantsAntimicrobial Agents and Chemotherapy, 2004
- Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent AdultsClinical Infectious Diseases, 2003
- Effects of an Efflux Mechanism and Ribosomal Mutations on Macrolide Susceptibility of Haemophilus influenzae Clinical IsolatesAntimicrobial Agents and Chemotherapy, 2003
- Mechanisms of Resistance to Macrolides and Lincosamides: Nature of the Resistance Elements and Their Clinical ImplicationsClinical Infectious Diseases, 2002
- Review of Macrolides and KetolidesDrugs, 2001
- Canadian Guidelines for the Initial Management of Community-Acquired Pneumonia: An Evidence-Based Update by the Canadian Infectious Diseases Society and the Canadian Thoracic SocietyClinical Infectious Diseases, 2000
- Severe Community-Acquired Pneumonia in the Elderly: Epidemiology and PrognosisClinical Infectious Diseases, 1996
- Otitis MediaClinical Infectious Diseases, 1994